Richard Ruiz, MD
Transplant Surgery · Dallas, TXNPI 1205861218
Payments from drug & device makers
What this record shows
This record is dominated by education: $14,554 of the $15,738 with a category attached, or 92.5%. Intuitive Surgical accounts for 95.7% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2023 at $15,145 and has fallen 99.0% since, to $154 in 2025.
Across 36 payments — averaging $437.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$15K
- AstraZeneca$133
- AbbVie$131
- Astellas Pharma US Inc$94
- Veloxis Pharmaceuticals, Inc.$82
- Abiomed$39
- plus $193 from 9 others
What the payments were for
- Travel & lodging$5423%
- Food & beverage$6424%
- Education$14,55492%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 10 | $15,066 |
| AstraZeneca | 3 | $133 |
| AbbVie | 6 | $131 |
| Astellas Pharma US Inc | 5 | $94 |
| Veloxis Pharmaceuticals, Inc. | 2 | $82 |
| Abiomed | 1 | $39 |
| Vifor Pharma, Inc. | 1 | $29 |
| Eisai Inc. | 1 | $26 |
| Apellis Pharmaceuticals, Inc. | 1 | $24 |
| GSK | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Merck | 1 | $20 |
| Smith+Nephew | 1 | $18 |
| Eurofins Viracor, LLC | 1 | $18 |
| Fresenius USA Marketing, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$14,500
- Da Vinci Surgical System$485
How this compares
$15,738 in reported general payments places this provider in the 85th percentile of 70 transplant surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other transplant surgery in Dallas
- Goran KlintmalmDallas$88K
- Alejandro MejiaDallas$20K
- Christie GoodenDallas$8K
- Steven HanishDallas$7K
- Lori KautzmanDallas$7K
- Jason SchwartzDallas$5K
- Tiffany AnthonyDallas$5K
- Anji WallDallas$4K
- Gregory McKennaDallas$4K
- Seung Hee LeeDallas$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.